Related Experiment Videos
Cardiac amyloidosis: a case report and therapeutic implications
Anu Radha Kotha1, Melvin B Weiss
1Division of Cardiology, New York Medical College/Westchester Medical Center, Valhalla, New York 10595, USA.
Heart Disease (Hagerstown, Md.)
|April 27, 2002
Abstract:
Primary amyloidosis with cardiac involvement presenting as congestive heart failure (CHF) usually carries an unfavorable prognosis, with median survival of about 6 months. We are reporting a case of cardiac amyloidosis with an initial presentation of CHF in which the patient survived for more than 9 years. The prognosis most likely depends on the period of disease remission (i.e., negative serum and urine immunoelectrophoresis), which, in turn, depends on response to chemotherapy.